Moreover, both CAMTA1 and DENND4A were independently found to be ‘Master Regulators’ (MRs) of neurodegenerative disease transcriptional programs in an in vivo Parkinson’s disease model and a cultured motor neuron-based ALS model (56,57). This evidence concerns the gene DENND4A and neurodegenerative disease.